Research Paper Volume 15, Issue 20 pp 11554—11570
Comprehensive analysis of transcriptome data and experimental identification show that solute carrier 35 member A2 (SLC35A2) is a prognostic marker of colorectal cancer
Figure 7. Construction of a nomogram to predict prognosis of patients with colorectal cancer. (A) Based on SLC35A2 expression and clinical characteristics of patients “TCGA-AA-A02K”, a nomogram was constructed. The 1, 3 and 5-years mortality rates of patient “TCGA-AA-A02K” were 0.292, 0.587 and 0.839, respectively. (B–D) The AUC of this nomogram with 1, 3 and 5-year ROC curves were 0.797, 0.8 and 0.818, respectively. (E–G) Calibration curves of 1, 3, and 5 years indicated that the nomogram was able to accurately predict colorectal cancer patients’ survival.